Molecular Markers of In Vivo<i>Plasmodium vivax</i>Resistance to Amodiaquine Plus Sulfadoxine‐Pyrimethamine: Mutations in<i>pvdhfr</i>and<i>pvmdr1</i>

Abstract

The present study identified a new molecular marker in pvmdr1 that is associated with the in vivo response to AQ+SP. We suggest suitable marker sets with which to monitor P. vivax resistance against AQ+SP in countries where these drugs are used.